Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.

Fernández, Ovidio; Afonso, Javier; Vázquez, Sergio; Campos, Begoña; Lázaro, Matín; León, Luis; Antón Aparicio, Luis M

Fernández, Ovidio; Afonso, Javier; Vázquez, Sergio; Campos, Begoña; Lázaro, Matín; León, Luis; Antón Aparicio, Luis M.

Affiliation

Fernández O; aOncology Service, Ourense's Hospital Complex, Ourense bMedical Oncology Service, Arquitecto Marcide's University Hospital cMedical Oncology Service, Santiago's University Clinical Hospital dMedical Oncology Service, A Coruña's University Hospital Complex, A Coruña eMedical Oncology Service, Lucus Augusti's University Hospital, Lugo fMedical Oncology Service, Xeral Cies de Vigo's University Hospital Complex, Pontevedra, Spain.

Anticancer Drugs ; 25(3): 237-43, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24217332

Subject(s)

Antineoplastic Agents/therapeutic use; Prostatic Neoplasms, Castration-Resistant/drug therapy; Taxoids/therapeutic use; Antineoplastic Agents/administration & dosage; Docetaxel; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms, Castration-Resistant/mortality; Prostatic Neoplasms, Castration-Resistant/pathology; Survival Rate; Taxoids/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Taxoids / Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Limits: Humans / Male Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2014 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google